Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin L Miller

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 29, 2018
Mutational Analysis Identifies Therapeutic Biomarkers in Inflammatory Bowel Disease-Associated Colorectal CancersShahida Din, Kim Wong, Mike F Mueller, et al.
Plos Computational Biology|December 25, 2013
Perturbation biology: inferring signaling networks in cellular systemsEvan J Molinelli, Anil Korkut, Weiqing Wang, et al.
Cancer Discovery|September 1, 2016
Integrin-α10 Dependency Identifies RAC and RICTOR as Therapeutic Targets in High-Grade MyxofibrosarcomaTomoyo Okada, Ann Y Lee, Li-Xuan Qin, et al.
Cell Reports|April 3, 2013
The SH2 domain interaction landscapeMichele Tinti, Lars Kiemer, Stefano Costa, et al.
Cancers|November 20, 2020
Integrated Multi-Tumor Radio-Genomic Marker of Outcomes in Patients with High Serous Ovarian CarcinomaHarini Veeraraghavan, Herbert Alberto Vargas, Alejandro Jimenez-Sanchez, et al.
Cell|August 26, 2017
Heterogeneous Tumor-Immune Microenvironments among Differentially Growing Metastases in an Ovarian Cancer PatientAlejandro Jiménez-Sánchez, Danish Memon, Stephane Pourpe, et al.
Journal for Immunotherapy of Cancer|May 19, 2026
Pan-cancer analysis in the real-world setting uncovers immunogenomic drivers of acquired resistance post-immunotherapyMohamed Reda Keddar, Sebastian Carrasco Pro, Roy Rabbie, et al.
British Journal of Cancer|March 30, 2021
Promises and challenges of adoptive T-cell therapies for solid tumoursMatteo Morotti, Ashwag Albukhari, Abdulkhaliq Alsaadi, et al.
Nature Communications|August 29, 2020
Multi-site clonality analysis uncovers pervasive heterogeneity across melanoma metastasesRoy Rabbie, Naser Ansari-Pour, Oliver Cast, et al.
Science (New York, N.Y.)|March 14, 2015
Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancerNaiyer A Rizvi, Matthew D Hellmann, Alexandra Snyder, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 29, 2018
Mutational Analysis Identifies Therapeutic Biomarkers in Inflammatory Bowel Disease-Associated Colorectal CancersShahida Din, Kim Wong, Mike F Mueller, et al.
Plos Computational Biology|December 25, 2013
Perturbation biology: inferring signaling networks in cellular systemsEvan J Molinelli, Anil Korkut, Weiqing Wang, et al.
Cancer Discovery|September 1, 2016
Integrin-α10 Dependency Identifies RAC and RICTOR as Therapeutic Targets in High-Grade MyxofibrosarcomaTomoyo Okada, Ann Y Lee, Li-Xuan Qin, et al.
Cell Reports|April 3, 2013
The SH2 domain interaction landscapeMichele Tinti, Lars Kiemer, Stefano Costa, et al.
Cancers|November 20, 2020
Integrated Multi-Tumor Radio-Genomic Marker of Outcomes in Patients with High Serous Ovarian CarcinomaHarini Veeraraghavan, Herbert Alberto Vargas, Alejandro Jimenez-Sanchez, et al.
Cell|August 26, 2017
Heterogeneous Tumor-Immune Microenvironments among Differentially Growing Metastases in an Ovarian Cancer PatientAlejandro Jiménez-Sánchez, Danish Memon, Stephane Pourpe, et al.
Journal for Immunotherapy of Cancer|May 19, 2026
Pan-cancer analysis in the real-world setting uncovers immunogenomic drivers of acquired resistance post-immunotherapyMohamed Reda Keddar, Sebastian Carrasco Pro, Roy Rabbie, et al.
British Journal of Cancer|March 30, 2021
Promises and challenges of adoptive T-cell therapies for solid tumoursMatteo Morotti, Ashwag Albukhari, Abdulkhaliq Alsaadi, et al.
Nature Communications|August 29, 2020
Multi-site clonality analysis uncovers pervasive heterogeneity across melanoma metastasesRoy Rabbie, Naser Ansari-Pour, Oliver Cast, et al.
Science (New York, N.Y.)|March 14, 2015
Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancerNaiyer A Rizvi, Matthew D Hellmann, Alexandra Snyder, et al.
Pageof 4